Web NewDrugInformation.com

Psorcon Drug - Psorcon The trade name of the product as shown on the labeling. Dosage - OINTMENT; TOPICAL The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Diflorasone Diacetate Multiple ingredients are in alphabetical order. Strength - 0.05% The potency of the active ingredient(s), Diflorasone Diacetate. May repeat for multiple part products. Applicant - PHARMACIA AND UPJOHN The firm name holding legal responsibility for Psorcon. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 019260 The FDA assigned number to Psorcon. Format is nnnnnn. Product Number - 001 The FDA assigned number to identify Psorcon. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - AB The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - Aug 28, 1985 The date Psorcon was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - Yes The pioneer or innovator of Psorcon. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - RX The group or category of approved drugs Psorcon is in. Format is RX, OTC, DISCN. Applicant Full Name - Pharmacia And Upjohn Co The full name of the firm holding legal responsibility for the new application of Psorcon. Psorcon Diflorasone Diacetate 0.05% Ointment; Topical Florone 0.05% Ointment; Topical Psorcon 0.05% Ointment; Topical Diflorasone Diacetate 0.05% Cream; Topical Diflorasone Diacetate 0.05% Cream; Topical Diflorasone Diacetate 0.05% Cream; Topical Florone 0.05% Cream; Topical Florone E 0.05% Cream; Topical Psorcon 0.05% Cream; Topical Diflorasone Diacetate 0.05% Ointment; Topical NewDrugInformation